Stanley Druckenmiller's RGEN Position Overview
Stanley Druckenmiller (via Duquesne Family Office LLC) currently holds 77,400 shares of Repligen Corporation (RGEN) worth $10.56 M, representing 0.20% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Stanley Druckenmiller has initiated a new position in RGEN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Stanley Druckenmiller's Repligen Corporation (RGEN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Repligen Corporation (RGEN) Trades by Stanley Druckenmiller
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +77,400 | New Buy | 77,400 | $136.43 |
Stanley Druckenmiller's Repligen Corporation Investment FAQs
Stanley Druckenmiller first purchased Repligen Corporation (RGEN) in Q2 2026, acquiring 77,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller has held Repligen Corporation (RGEN) for 1 quarters since Q2 2026.
Stanley Druckenmiller's largest addition to Repligen Corporation (RGEN) was in Q2 2026, adding 77,400 shares worth $10.56 M.
According to the latest 13F filing for Q2 2026, Stanley Druckenmiller's firm, Duquesne Family Office LLC, owns 77,400 shares of Repligen Corporation (RGEN), valued at approximately $10.56 M.
As of the Q2 2026 filing, Repligen Corporation (RGEN) represents approximately 0.20% of Stanley Druckenmiller's publicly disclosed stock portfolio, making it one of their key holdings.
Stanley Druckenmiller's peak holding in Repligen Corporation (RGEN) was 77,400 shares, as reported at the end of Q2 2026.